About (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide
(NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide (PubChem CID 52912271) has the molecular formula C23H13BrClF3N4O4S2
and a molecular weight of 645.87 g/mol. Its IUPAC name is (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide.
Molecular Properties
| Compound Name | (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide |
| PubChem CID | 52912271 |
| Molecular Formula | C23H13BrClF3N4O4S2 |
| Molecular Weight | 645.87 g/mol |
| Exact Mass | 643.92 |
| IUPAC Name | (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide |
| SMILES | O=C1CS/C(=N\S(=O)(=O)c2ccc(-n3nc(C(F)(F)F)c(Br)c3-c3ccco3)cc2)N1c1ccc(Cl)cc1 |
| InChI | InChI=1S/C23H13BrClF3N4O4S2/c24-19-20(17-2-1-11-36-17)32(29-21(19)23(26,27)28)15-7-9-16(10-8-15)38(34,35)30-22-31(18(33)12-37-22)14-5-3-13(25)4-6-14/h1-11H,12H2/b30-22- |
| InChIKey | SJJFJATZBOEOQD-SWKFRHMKSA-N |
| XLogP | 6.39 |
| TPSA | 97.77 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 645.87 |
| LogP ≤ 5 | 6.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Analyze (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide?
The IUPAC name of (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide (CID 52912271) is (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide.
What is the SMILES notation for (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide?
The canonical SMILES for (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide is O=C1CS/C(=N\S(=O)(=O)c2ccc(-n3nc(C(F)(F)F)c(Br)c3-c3ccco3)cc2)N1c1ccc(Cl)cc1.
What is the InChIKey of (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide?
The InChIKey is SJJFJATZBOEOQD-SWKFRHMKSA-N. The full InChI is InChI=1S/C23H13BrClF3N4O4S2/c24-19-20(17-2-1-11-36-17)32(29-21(19)23(26,27)28)15-7-9-16(10-8-15)38(34,35)30-22-31(18(33)12-37-22)14-5-3-13(25)4-6-14/h1-11H,12H2/b30-22-.
What are the key properties of (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide?
(NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide has a molecular weight of 645.87 g/mol, XLogP of 6.39, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (NZ)-4-[4-bromo-5-(furan-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]-N-[3-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-2-ylidene]benzenesulfonamide is sourced from PubChem (CID 52912271), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).